Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Clinical trial NCT06037811 · RECRUITING

Trial details

NCT number: NCT06037811
Sponsor: Tom Appleton
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Inflammatory Arthritis Immune-related Adverse Event

Start date: 2024-04-15
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.